Glycated Hemoglobin (Hba1c), Blood Glucose, and Chromium Levels among Type 2 Diabetic Patients: A Cross-Sectional Study in Denpasar, Bali
Keywords:
blood glucose, chromium, diabetes, HbA1c.Abstract
Results of Basic Health Research (Riskesdas) in 2013 showed that the prevalence of diabetes in Indonesia was 2.1%, and the highest prevalence was found among the age group of over 55 years in urban areas. Poor blood glucose control remains an issue among patients with type 2 diabetes mellitus (T2DM) and they are predicted to have micronutrients deficiency.
This study aimed to describe HbA1c, blood glucose and serum chromium levels among T2DM patients. It was conducted from July 2015 to January 2016 in six public health centers (Puskesmas) in City of Denpasar. It was a cross sectional study with 165 subjects selected randomly from those who met the inclusion and exclusion criteria in each PHC. The data collected were HbA1c, blood sugar and chromium levels. HbA1c was measured by using HPLC method and blood glucose level was determined using GOD-PAP enzymatic colorimetric method, while chromium level in serum was measured by AAS method. Median of HbA1c level was 7.1%, median of fasting blood glucose level was 140 mg/dL, and mean of serum chromium level was 42.3 µg/L with an SD of 16.0 µg/L. Although T2DM patients have been getting medical treatment, they have poor glycemic control and lower chromium level compared to non-diabetic subjects in the same area.
References
International Diabetes Federation (IDF). (2013). Diabetes Atlas.(6th edition). [Online]. Available: www.idf.org/diabetesatlas [March 29, 2014].
Badan Penelitian dan Pengembangan Kesehatan RI (Balitbangkes RI). Laporan Riset Kesehatan Dasar 2013. Jakarta: KementerianKesehatan RI, 2013.
Badan Penelitian dan Pengembangan Kesehatan RI (Balitbangkes RI). Laporan Riset Kesehatan Dasar 2007. Jakarta: Kementerian Kesehatan RI, 2007.
American Diabetes Association (ADA).“Diagnosis and classification of diabetesmellitus”. Diabetes Care, vol. 34, pp. s62-s69, Jan. 2011.
K. Khunti, T. Damci, L. Meneghini, C.Y. Pan, J.F. Yale; SOLVE Study Group. “Study of Once Daily Levemir (SOLVETM): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice”. Diabetes, Obesity and Metabolism, vol.14, pp. 654-661, Jul. 2012.
American Diabetes Association (ADA). “Standards of medical care in diabetes”. Diabetes Care, vol. 39, pp. s1-s119, Jan. 2015.
R.W. Tuman, R.J. Doisy. “Metabolic effects of the glucose tolerance factor (GTF) in normal and genetically diabetic mice”. Diabetes, vol. 26, pp. 820-826, Sep. 1977.
D. Ghosh, B. Bhattacharya, B. Mukherjee, B. Manna, M. Sinha, J. Chowdhury et al. “Role of chromium supplementation in Indians with type 2 diabetes mellitus”. The Journal of Nutritional Biochemistry, vol. 13, pp. 690-697, Nov. 2002.
F.B. Hu. “Globalization of diabetes: the role of diet, lifestyle and genes”. Diabetes Care, vol. 34, pp. 1249–1257, Jun. 2011.
K.H. Yoon, J.H. Lee, J.W. Kim, J.H. Cho, Y.H. Choi, S.H. Ko, et al. “Epidemic obesity and type 2 diabetes in Asia”. Lancet, vol. 368, pp. 1681-1688, Nov. 2006.
A. Misra, A. Ramachandran, R. Jayawardena, U. Shrivastava, C. Snehalatha C. “Diabetes in South Asians”. Diabetic Medicine, vol. 31, pp. 1153-1162, Oct. 2014.
M. Khattab, Y.S. Khader, A. Al-Khawaldeh, K. Ajlouni. “Factors associated with poor glycemic control among patients with type 2 diabetes”. Journal of Diabetes and Its Complications, vol. 24, pp. 84-89, 2010.
N. Kleefstra, S.T. Houweling, F.G. Jansman, K.H. Gronier, R.O. Gans, B. Meyboom-de Jong et al.“Chromium treatment has no effect inpatients with poorly controlled, insulin-treated type 2 diabetes in an obeseWestern population. Diabetes Care, vol. 29, pp. 521–525, Mar. 2006.
H.G. Hasan, P.A. Ismael, N.M. Aziz. “Evaluation of serum chromium levels in patients with type 1 and 2 diabetes mellitus and insulin resistance”. International Journal of Basic and Applied Sciences, vol. 12, pp. 69-73, 2012.
N. Kleefstra, S.T. Houweling, S.J. Bakker, S. Verhoeven, R.O. Gans, B. Meyboom-de Jong et al. “Chromium treatment has no effect inpatients with type 2 diabetes in aWestern population: a randomized, double-blind, placebo-controlled trial”. Diabetes Care, vol.30, pp. 1092–1096, May 2007.
A.C. Nsonwu, C.A.O. Usoro, M.H. Etukudo, I.N. Usoro. “Serum and urine levels of chromium and magnesium in type 2 diabetics in Calabar, Nigeria”. Malaysian Journal of Nutrition, vol. 11, pp. 133-142, 2005.
A.G. Diwan, A.B. Pradham, D. Lingojwar, K.K. Krishna, P. Singh, S.L. Almelkar. “Serum zinc, chromium and magnesium levels in type 2 diabetes”. International Journal of Diabetes in Developing Countries, vol.26, pp. 122-123, 2006.
K. Rajendran, S. Manikandan, L.D. Nair, R. Karuthodiyil, N. Vijayarajan, R. Gnanasekar, et al. “Serum chromium levels in type 2 diabetic patients and its association with glycaemic control”. Journal of Clinical and Diagnostic Research, vol. 9, pp. OC05-OC08, Nov. 2015.
D.L. Watts. (1999). “Trace elements and Glucose Disorder”. Trace Elements, Inc Newsletter, vol. 11(2), pp. 1-7.
A.D. Mooradian, M. Failla, B. Hoogwerf, M. Marynuik, J. Wylie-Rosett. “Selected vitamins and minerals in diabetes”. Diabetes Care, vol. 17, pp. 464-479, May 1994.
Z.Q. Wang, W.T. Cefalu. “Current concepts about chromium supplementation in type 2 diabetes and insulin resistance”. Current Diabetes Reports, vol. 10, pp. 145-151, Apr. 2010.
R.A. Anderson, A.S. Kozlovsky. “Chromium intake, absorption and excretion of subjects consumingself-selected diets”. American Journal of Clinical Nutrition, vol. 41, pp. 1177-1183, Jun. 1985.
S. Davies, H.J. McLaren, A. Hunnisett, M. Howard. “Age-related decreases in chromium levels in 51,665 hair, sweat, and serum samples from 40,872 patients: implications for the prevention of cardiovascular disease and type II diabetes mellitus”. Metabolism, vol. 46, pp. 469–473, May 1997.
UK Prospective Diabetes Study Group (UKPDS) Group. “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes [UKPDS 33]”. Lancet, vol. 352, pp. 837-853, Sep. 1998.
A. Muula. “Preventing diabetes-associated morbidity and mortality in resource poor communities”. Diabetes International, vol. 10, pp. 47-48, 2000.
E. Bonora, C. Francesco, L. Simonetta L, N.Bonfante. “Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes: Implications for treatment and monitoring of metabolic control”. Diabetes Care, vol. 24, pp. 2023-2029, Dec. 2001.
S. Gupta, P.V. Puppalwar, A. Chalak. “Correlation of fasting and post meal plasma glucose level to increased HbA1c levels in type 2 diabetes mellitus”. International Journal of Advances in Medicine, vol. 1, pp. 127-131, 2014.
N.K. Swetha. “Comparison of fasting blood glucose & post prandial blood glucose with HbA1c in assessing the glycemic control”. International Journal of Healthcare and Biomedical Research, vol. 2, pp. 134-139, 2014.
E.B. Ketema EB, K.T. Kibret. “Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control: systematic review and meta-analysis”. Archives Public Health, vol. 73, pp. 43-51, Sep. 2015.
A. Ramachandran, M.C. Riddle, C. Kabali, H.C. Gerstein HC. “Relationship between A1C and fasting plasma glucose in dysglycemia or type 2 diabetes”. Diabetes Care, vol. 35, pp. 749-753, 2012.
Downloads
Published
How to Cite
Issue
Section
License
Authors who submit papers with this journal agree to the following terms.
